Specialty Directorship · GLP-1 & Weight Loss

Weight Loss Medical Director in Arizona

Specialty Medical Director services for Arizona medical weight-loss clinics and GLP-1 programs prescribing semaglutide, tirzepatide, and compounded weight-management medications. Prescriptive authority, GLP-1 titration protocols, patient eligibility screening, side-effect management, compounded-pharmacy coordination, and RN delegation — the full clinical framework a weight-loss clinic needs to operate legally and safely in Arizona. Delivered by Naomi Fayzulayev, FNP-C, an AZ-licensed, full-practice-authority Family Nurse Practitioner.

Serving All of Arizona
Beso Provider Hub
4731 E Union Hills Dr, Suite 114
Phoenix, AZ 85050
Weight-loss directorship for clinics across Phoenix, Scottsdale, Mesa, Chandler, Gilbert, Tempe, Peoria & Glendale. Retainers scoped to program size and patient volume.

Why GLP-1 directorship demands more than a signature.

The GLP-1 weight-loss boom is real — and so is the regulatory scrutiny that follows it. Semaglutide and tirzepatide are prescription medications with a defined side-effect profile, real contraindications, and an evolving compliance landscape around compounded formulations. A weight-loss clinic that treats directorship as a name on paperwork is exactly the kind of practice that draws a Board of Nursing or Board of Pharmacy inquiry when something goes wrong.

A defensible GLP-1 directorship means the Medical Director actually owns the clinical layer: the eligibility criteria that keep unsuitable patients out, the titration protocol that manages nausea and GI effects, the red-flag screening for pancreatitis and gallbladder disease, the personal and family history screening for medullary thyroid carcinoma and MEN2, and the documentation that holds up if a patient has an adverse event.

Beso Provider Hub provides that full framework. As an actively-practicing FNP-C with full prescriptive authority in Arizona, Naomi Fayzulayev prescribes and manages weight-management protocols — so the standing orders your clinic runs on are clinically current, not copied from a template. The compounded-GLP-1 regulatory landscape in particular is shifting quickly; protocols need a director who tracks FDA and state Board of Pharmacy guidance, not one who set them up once and disappeared.

For context on retainer ranges across specialties, see our 2026 Arizona MD Cost Benchmark. If your clinic also runs IV therapy or hormones alongside weight loss, those layer into a single combined engagement — see IV Therapy Medical Director.

Full-practice-authority prescriber
In Arizona, a board-certified NP can prescribe semaglutide and tirzepatide and serve as Medical Director independently — no supervising physician or collaboration agreement required.
Current on compounded-GLP-1 rules
The compliance landscape around compounded semaglutide and tirzepatide is evolving fast. Protocols are maintained to current FDA and AZ Board of Pharmacy guidance — not left to go stale.
Real side-effect management
Documented protocols for nausea, GI effects, gallbladder and pancreatitis red flags, and dose-adjustment thresholds — the clinical judgment a GLP-1 program actually needs.

Weight-loss programs we build the framework for.

Every medication and program on your menu gets its own written protocol — eligibility, titration, monitoring, and adverse-event response. Below is the modern medical weight-loss menu.

GLP-1 Agonist
Semaglutide
Weekly semaglutide protocols — brand and compounded. Eligibility criteria, dose-escalation schedule, nausea and GI management, and monitoring parameters at each titration step.
Dual GIP/GLP-1
Tirzepatide
Weekly tirzepatide protocols with the distinct titration schedule and side-effect profile of the dual GIP/GLP-1 mechanism. Eligibility, escalation, and monitoring specific to the molecule.
Compounded
Compounded GLP-1 Formulations
Protocols for compounded semaglutide/tirzepatide with pharmacy licensure and 503A/503B verification, clinical rationale documentation, and formulation-specific concentration and dosing.
Adjunct
Lipotropic & B12 Injections
MICC / lipotropic and B12 injection protocols as GLP-1 adjuncts or standalone weight-management support. Standing orders for RN administration under delegation.
Adjunct Oral
Appetite-Suppressant & Metabolic Rx
Where clinically appropriate, protocols for adjunct oral agents (phentermine, naltrexone/bupropion, metformin) with contraindication screening and monitoring.
Program Design
Intake, Labs & Follow-Up Cadence
Baseline lab panels, follow-up schedule, weight and vitals tracking framework, and the documentation cadence that keeps the program defensible and outcomes measurable.

The screening & safety protocols that matter most.

GLP-1 programs live or die on patient selection and side-effect management. Every one of these is built and maintained as part of the engagement.

Eligibility & BMI Criteria
Documented eligibility thresholds (BMI plus comorbidity criteria), so patients are selected on clinical grounds — not just willingness to pay.
MTC / MEN2 Screening
Personal and family history screening for medullary thyroid carcinoma and Multiple Endocrine Neoplasia type 2 — an absolute contraindication that must be documented at intake.
Pancreatitis & Gallbladder
History screening and red-flag protocols for pancreatitis and gallbladder disease, with clear escalation criteria for patients who develop symptoms on therapy.
Titration & GI Management
Dose-escalation schedules that minimize nausea, vomiting, and GI effects, with pause-and-hold thresholds and patient guidance at every step.
Contraindication Screening
Pregnancy, type 1 diabetes, diabetic retinopathy considerations, medication interactions, and eating-disorder history — documented at intake and reassessed.
Adverse-Event Response
Written response protocols for suspected pancreatitis, severe GI effects, dehydration, and hypoglycemia in patients on concurrent diabetes medications.

What’s included for Arizona weight-loss clinics.

Every weight-loss MD engagement includes the following. The GLP-1 protocol library and eligibility framework are the deliverables that separate real directorship from paperwork.

✓ Signed Medical Director Agreement
Executable contract identifying scope, responsibilities, and weight-loss-specific coverage.
✓ Prescriptive Authority for GLP-1s
AZ-licensed FNP-C prescriber for semaglutide, tirzepatide, and adjunct weight-management medications.
✓ GLP-1 Titration Protocols
Per-medication dose-escalation schedules with monitoring parameters at each step.
✓ Patient Eligibility & Screening
BMI criteria, MTC/MEN2 screening, contraindication logic, and intake documentation.
✓ Side-Effect & Adverse-Event Protocols
Nausea/GI management, pancreatitis and gallbladder red flags, and escalation criteria.
✓ Compounded Pharmacy Coordination
Pharmacy licensure and 503A/503B verification, and compounded-formulation documentation.
✓ Consent & Intake Documentation
GLP-1-specific consent forms, medical history intake, and baseline lab/vitals templates.
✓ RN Delegation Framework
Written authorization for RN staff to perform intake and administer GLP-1 injections.
✓ Defined-Response Emergency Consultation
Direct clinical access for real-time questions when a patient has an unexpected reaction.
✓ Ongoing Chart Review
Scheduled documentation review at cadence matched to your patient volume.
✓ Regulatory-Change Protocol Updates
Protocols updated as FDA and AZ Board of Pharmacy guidance on compounded GLP-1s evolves.
✓ Quarterly Compliance Check-Ins
Documentation currency, regulatory changes, and program review each quarter.

Common questions from weight-loss clinic operators.

Does a weight-loss clinic need a medical director in Arizona?
Yes. Semaglutide, tirzepatide, and other GLP-1 medications are prescription drugs. A weight-loss clinic or GLP-1 program operating without a Medical Director is not legal in Arizona — this applies even to RN-owned or non-clinical-owner businesses, since neither can prescribe GLP-1 medications.
Can a Nurse Practitioner be the medical director for a GLP-1 clinic?
Yes. Arizona is a full practice authority state. A board-certified NP can prescribe semaglutide and tirzepatide, set protocols, and serve as Medical Director independently — no supervising physician or collaboration agreement required. Naomi Fayzulayev, FNP-C provides this across Arizona.
Can RNs administer semaglutide or tirzepatide under a medical director?
Yes. Injection administration is within RN scope. The RN cannot prescribe or independently determine eligibility — but under written standing orders and delegation, an RN can perform intake, administer the injection, and provide education. See our MD for RNs page for the full delegation framework.
What about compounded semaglutide and tirzepatide?
Compounded GLP-1s carry extra oversight: the MD verifies the compounding pharmacy’s licensure and 503A/503B status, documents the clinical rationale for compounded vs brand, and maintains formulation-specific protocols. As the regulatory landscape evolves, a director who actively tracks FDA and Board of Pharmacy guidance is essential.
What is included in the service?
Signed MD Agreement, prescriptive authority, GLP-1 titration protocols, patient eligibility and screening (BMI, MTC/MEN2, pancreatitis, contraindications), side-effect and adverse-event protocols, compounded pharmacy coordination, consent forms, RN delegation, chart review, emergency consultation, and quarterly compliance check-ins. See the “What’s Included” section above.
How much does it cost?
Arizona MD retainers typically range from $1,500 to $5,000/month. A weight-loss-only clinic usually prices in the lower-to-mid range; clinics combining weight loss with IV, hormones, or aesthetics, or running high volume across locations, price higher. See the 2026 Arizona MD Cost Benchmark.
Can you help launch a new weight-loss clinic?
Yes. Launch Package engagements combine pre-open protocol buildout (titration protocols, eligibility screening, consent, standing orders, RN delegation, adverse-event protocols) with 90 days of active directorship from day one of patient care.
Does the medical director need to be on-site?
For most weight-loss clinics operating under delegated authority, no. Off-site directorship via written protocols, standing orders, scheduled chart review, and emergency consultation is standard. Initial patient evaluation workflow is scoped in the standing orders based on your clinic’s model.

Opening or running a weight-loss clinic in Arizona? —
get the clinical framework right.

Twenty-minute discovery call. Written scoped quote within one business day. GLP-1 protocols built and maintained by an actively-practicing AZ FNP-C. No obligation.

Book a Discovery Call →